SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 201.29+0.2%Nov 17 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: medsunman who wrote (11167)11/15/1997 3:22:00 PM
From: Henry Niman  Read Replies (1) of 32384
 
medsunman, I had guessed that upfront fees could be as high as $100 million. The LLY deal had about $60 million up front with much more to come from milestones shortly (much of the additional $75 million in milestones will be paid when the diabetes trial begins in the US and INDs are filied for additional rexinoids - these events are slated for 1998).
I'm still expecting the 3 news articles as well as new coverage by analysts.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext